| HOME >> BIOLOGY >> TECHNOLOGY |
(expressed in Canadian dollars)
------------ ------------
2007 2006
------------ ------------
$ $
Cash provided by (used in)
Operating activities
Net and comprehensive loss for the period (15,418,677) (14,127,086)
Add items not affecting cash:
Amortization 1,390,065 832,845
Acquisition of intellectual
property for warrants - 1,516,906
Write down of property and equipment - 161,732
Loss on sale of property and equipment 1,483 16,802
Stock-based compensation 723,558 713,902
Unrealized foreign exchange (gain) loss (220,554) 41,900
Non-cash interest expense 4,994 -
------------ ------------
(13,519,131) (10,842,999)
Change in non-cash working capital and
other balances related to operations 578,174 (251,140)
------------ ------------
(12,940,957) (11,094,139)
------------ ------------
Financing activities
Issuance of capital stock 24,331,688 -
Share issue costs (2,256,728) (20,284)
Issuance of warrants 1,140,800 -
Warrant issue costs
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |